Rebecca A. Nace - Search Results

Year	Number of Results
2013	1
2016	2
2019	1
2020	3
2021	5
2022	3
2023	1

1

Unlocking loxP to Track Genome Editing In Vivo.

Gendron WAC, Rubin JD, Hansen MJ, Nace RA, Simone BW, Ekker SC, Barry MA. Gendron WAC, et al. Among authors: nace ra. Genes (Basel). 2021 Aug 3;12(8):1204. doi: 10.3390/genes12081204. Genes (Basel). 2021. PMID: 34440379 Free PMC article.

2

MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.

Ruiz AJ, Hadac EM, Nace RA, Russell SJ. Ruiz AJ, et al. Among authors: nace ra. J Virol. 2016 Mar 28;90(8):4078-4092. doi: 10.1128/JVI.02810-15. Print 2016 Apr. J Virol. 2016. PMID: 26865716 Free PMC article.

3

MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.

Muñoz-Alía MÁ, Nace RA, Tischer A, Zhang L, Bah ES, Auton M, Russell SJ. Muñoz-Alía MÁ, et al. Among authors: nace ra. PLoS Pathog. 2021 Feb 3;17(2):e1009283. doi: 10.1371/journal.ppat.1009283. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33534834 Free PMC article.

4

Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA.

Elsedawy NB, Nace RA, Russell SJ, Schulze AJ. Elsedawy NB, et al. Among authors: nace ra. Mol Ther Oncolytics. 2020 May 19;17:484-495. doi: 10.1016/j.omto.2020.05.003. eCollection 2020 Jun 26. Mol Ther Oncolytics. 2020. PMID: 32529026 Free PMC article.

5

Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants.

Muñoz-Alía MÁ, Nace RA, Balakrishnan B, Zhang L, Packiriswamy N, Singh G, Warang P, Mena I, Narjari R, Vandergaast R, García-Sastre A, Schotsaert M, Russell SJ. Muñoz-Alía MÁ, et al. Among authors: nace ra. bioRxiv. 2022 Dec 16:2022.12.16.520799. doi: 10.1101/2022.12.16.520799. Preprint. bioRxiv. 2022. PMID: 36561187 Free PMC article.

6

Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells.

Budzik KM, Nace RA, Ikeda Y, Russell SJ. Budzik KM, et al. Among authors: nace ra. J Virol. 2021 Mar 10;95(10):e00015-21. doi: 10.1128/JVI.00015-21. Online ahead of print. J Virol. 2021. PMID: 33692205 Free PMC article.

7

Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9.

Eckert EC, Nace RA, Tonne JM, Evgin L, Vile RG, Russell SJ. Eckert EC, et al. Among authors: nace ra. Mol Ther Oncolytics. 2019 Dec 14;16:63-74. doi: 10.1016/j.omto.2019.12.003. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2019. PMID: 31930167 Free PMC article.

8

MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model.

Suryawanshi YR, Nace RA, Russell SJ, Schulze AJ. Suryawanshi YR, et al. Among authors: nace ra. Mol Ther Oncolytics. 2021 Aug 25;23:1-13. doi: 10.1016/j.omto.2021.08.011. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34589580 Free PMC article.

9

Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.

Budzik KM, Nace RA, Ikeda Y, Russell SJ. Budzik KM, et al. Among authors: nace ra. Cancer Gene Ther. 2022 Aug;29(8-9):1240-1251. doi: 10.1038/s41417-022-00431-y. Epub 2022 Feb 10. Cancer Gene Ther. 2022. PMID: 35145270 Free PMC article.

10

Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins.

Muñoz-Alía MÁ, Nace RA, Zhang L, Russell SJ. Muñoz-Alía MÁ, et al. Among authors: nace ra. Cell Rep Med. 2021 Mar 30;2(4):100225. doi: 10.1016/j.xcrm.2021.100225. eCollection 2021 Apr 20. Cell Rep Med. 2021. PMID: 33948566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results